These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 26038841)

  • 21. Verification of serum reference intervals for free light chains in a local South African population.
    Zemlin AE; Rensburg MA; Ipp H; Germishuys JJ; Erasmus RT
    J Clin Pathol; 2013 Nov; 66(11):992-5. PubMed ID: 23801498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical Significance of Serum Free Light Chain and Its κ/λ Ratio in Patients with Multiple Myeloma].
    Zhao D; Jiang JQ; Lin L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Aug; 27(4):1173-1178. PubMed ID: 31418375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of renal function on the clinical performance of FLC measurement in AL amyloidosis.
    Palladini G; Milani P; Foli A; Basset M; Russo F; Bosoni T; Pirolini L; Valentini V; Ferraro G; Lavatelli F; Barassi A; Albertini R; Merlini G
    Clin Chem Lab Med; 2016 Jun; 54(6):939-45. PubMed ID: 26943606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Higher serum levels of free ĸ plus λ immunoglobulin light chains ameliorate survival of hemodialysis patients.
    Thilo F; Caspari C; Scholze A; Tepel M
    Kidney Blood Press Res; 2011; 34(5):344-9. PubMed ID: 21646814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Judging disease activity in rheumatoid arthritis by serum free kappa and lambda light chain levels.
    Ye Y; Li SL; Xie M; Jiang P; Liu KG; Li YJ
    Kaohsiung J Med Sci; 2013 Oct; 29(10):547-53. PubMed ID: 24099109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical specificity of two assays for immunoglobulin kappa and lambda free light chains.
    Farnsworth CW; Roemmich B; Spears GM; Murray DL; Dispenzieri A; Willrich MAV
    Clin Chem Lab Med; 2024 Apr; 62(5):929-938. PubMed ID: 38044587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Association between Polyclonal Combined Serum Free Light Chain Concentration and Mortality in Individuals with Early Chronic Kidney Disease.
    Assi LK; McIntyre N; Fraser S; Harris S; Hutchison CA; McIntyre CW; Cockwell P; Taal MW
    PLoS One; 2015; 10(7):e0129980. PubMed ID: 26132658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel extended reference range for serum kappa/lambda free light chain ratio in diagnosing monoclonal gammopathies in renal insufficient patients.
    Diamantidis MD; Ioannidou-Papagiannaki E; Ntaios G
    Clin Biochem; 2009 Jul; 42(10-11):1202-3. PubMed ID: 19375413
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinic-pathological characteristics of rare tubulointerstitial diseases.
    Shi K; Yuan S; Huang Y; Li Z; Wang C; Liu H; Sun L; Liu F; Zhu X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Oct; 47(10):1365-1374. PubMed ID: 36411687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma.
    Kyrtsonis MC; Vassilakopoulos TP; Kafasi N; Sachanas S; Tzenou T; Papadogiannis A; Galanis Z; Kalpadakis C; Dimou M; Kyriakou E; Angelopoulou MK; Dimopoulou MN; Siakantaris MP; Dimitriadou EM; Kokoris SI; Panayiotidis P; Pangalis GA
    Br J Haematol; 2007 May; 137(3):240-3. PubMed ID: 17408464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kidney failure as an unusual initial presentation of biclonal gammopathy (IgD multiple myeloma associated with light chain disease)--a case report.
    Rabrenović V; Mijušković Z; Marjanović S; Rabrenović M; Jovanović D; Antić S; Ignjatović L; Petrović M; Pilcević D
    Vojnosanit Pregl; 2015 Feb; 72(2):196-9. PubMed ID: 25831916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measurement of free kappa and lambda chains in serum and the significance of their ratio in patients with multiple myeloma.
    Nelson M; Brown RD; Gibson J; Joshua DE
    Br J Haematol; 1992 Jun; 81(2):223-30. PubMed ID: 1643019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of kappa and lambda light chain monoclonal proteins in human serum: automated immunoassay versus immunofixation electrophoresis.
    Jaskowski TD; Litwin CM; Hill HR
    Clin Vaccine Immunol; 2006 Feb; 13(2):277-80. PubMed ID: 16467338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of Haemodiafiltration with Heat Sterilized High-Flux Polyphenylene HF Dialyzer in Reducing Free Light Chains in Patients with Myeloma Cast Nephropathy.
    Rousseau-Gagnon M; Agharazii M; De Serres SA; Desmeules S
    PLoS One; 2015; 10(10):e0140463. PubMed ID: 26466100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Verification of Newly FDA-Approved Kappa and Lambda Free Light Chain Assays on a Previously Untested Platform.
    Muluhngwi P; Sharp CN; Pozzi N; Elin RJ; Jortani SA
    J Appl Lab Med; 2019 Nov; 4(3):323-330. PubMed ID: 31659070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Laboratory diagnosis of monoclonal gammopathies. Prospective study of 14 cases in Dakar, Senegal].
    Diop PA; Haudrechy D; Sylla-Niang M; Diedhiou A; Ngom L; Lopez-Sall P
    Bull Soc Pathol Exot; 1998; 91(3):242-6. PubMed ID: 9773201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Measurement of serum free light chains and its clinical significance in 20 newly diagnosed patients of multiple myeloma].
    Mao XB; Chen XQ; Zhai YP; Liang R; Gao GX; Ma GG; Yu YP; Li F
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):829-32. PubMed ID: 18718070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of serum free light chain levels in healthy adults immediately after marathon running.
    Campbell JP; Eijsvogels TM; Wang Y; Hopman MT; Jacobs JF
    Clin Chem Lab Med; 2016 Mar; 54(3):459-65. PubMed ID: 26351935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Expression and significance of immunoglobulin free light chains in serum and lung tissues from patients with chronic obstructive pulmonary disease].
    Zhang M; Tao HC; Li YQ; Pei HS; Zhu SY; Chen B; Zhou RJ; Zhang MW
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Dec; 36(12):945-9. PubMed ID: 24503428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reference Intervals for Plasma Free Kappa and Lambda Chains and Kappa/Lambda Ratio using PENIA.
    Rollborn N; Kultima K; Larsson A
    Clin Lab; 2023 Aug; 69(8):. PubMed ID: 37560857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.